Whatsapp        info@iclmedilab.com        +91 7593854250        +91 480 2833150
Home   >   About Us

ICL MediLab is a High-tech medical laboratory engaged in clinical trials and analytics. We are based in Irinjalakuda, a small town of Thrissur District in Kerala. ICL Medilab is a subsidiary of ICL Fincorp Ltd., the leading NBFC Company based in Kerala that has branches all over South India with the leadership of Sri. K.G. Anil Kumar, Chairman and Managing Director have registered an impressive growth since its inception.

ICL Medilab apart from being a high tech lab is also the first Vaso Meditech EECP Center in Kerala. Our highly skilled doctors and staff with extensive experience in running EECP centres are ready to offer EECP therapy treatment to anyone who experiences heart pain and have an arterial block that prevents pumping of an adequate amount of blood to the heart. The EECP treatment method is also found to be effective for those who underwent bypass surgery and stent fixing.

We are also the exclusive franchisee of Vaso Meditech EECP machines in Kerala and have plans to expand the EECP centres to other parts of Kerala in due course.

Apart from offering standard laboratory services, including a whole range of testing analysis such as blood, urine, sputum and stool, we also offer other high tech testing equipment for the first time in Kerala.

Our Mission

  • To continue delivering unmatched Vaso-Meditech EECP treatment and patient care, improve the cardiac health of patients and be a centre of research, development, care, innovation and excellence.

  • To spread the message of EECP and ensure the benefits of Vaso-Meditech EECP are accessible to patients from all strata of society.

  • To create word largest chain of EECP centers for Advanced Heart Failure Treatment Program [AHFTP] and non invasive Ischemic burden Induction Program [NIBR-P].

Our Vision

  • To be a world leader in non-invasive cardiac care and enhance the quality of life

  • To contribute original research article and education manual to increase the understanding and clinical validation of Vaso-Meditech EECP treatment.